|
Status |
Public on Sep 16, 2017 |
Title |
RNA sequencing analysis of HL-1 cardiomyocytes |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Analysis of murine cardiomyocyte cell line HL-1 treated with Ivermectin or Importazole. Results provide insight into the pathways regulated by the treatments.
|
|
|
Overall design |
RNA-seq of mouse HL-1 cardiomyocytes treated with vehicle (DMSO), Ivermectin, or Importazole for 24 hours, in triplicate, using Ion Proton System.
|
|
|
Contributor(s) |
Satomi T, Nagai H, Kikuchi K, Tozaki H |
Citation(s) |
28942281 |
Submission date |
Mar 23, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Yoshiyuki Tsujihata |
E-mail(s) |
yoshiyuki.tsujihata@takeda.com
|
Phone |
+81-466-32-1788
|
Organization name |
Takeda Pharmaceutical Company Limited
|
Street address |
26-1, Muraoka-Higashi 2-chome
|
City |
Fujisawa |
State/province |
Kanagawa |
ZIP/Postal code |
2518555 |
Country |
Japan |
|
|
Platforms (1) |
GPL18635 |
Ion Torrent Proton (Mus musculus) |
|
Samples (9)
|
|
This SubSeries is part of SuperSeries: |
GSE96989 |
RNA sequencing analysis of cardiomyocytes |
|
Relations |
BioProject |
PRJNA380279 |
SRA |
SRP102431 |